肺炎克雷伯氏菌

  • 网络klebsiella pneumoniae
肺炎克雷伯氏菌肺炎克雷伯氏菌
  1. 产ESBLs的肺炎克雷伯氏菌、大肠埃希氏菌分别有7株(41.2%)和4株(28.6%);

    Seven ( 41.2 % ) of the Klebsiella pneumoniae and 4 ( 28.6 % ) of the Escherichia coli produced ESBLs .

  2. GB/T14926.13-1994实验动物肺炎克雷伯氏菌检验方法

    Method for examination of Klebsiella pneumoniae in laboratory animal

  3. 肺炎克雷伯氏菌AmpCβ-内酰胺酶动力学及抑酶效应的研究

    Study of kinetics of AmpC β - lactamase in Klebsiella pneumoniae and the inhibitory activity of β - lactamase inhibitors

  4. 了解四川大学华西医院产ESBLs肺炎克雷伯氏菌和大肠埃希氏菌的TEM或SHV型ESBLs,并探讨ESBLs进化及分类关系。

    To identify TEM-type and SHV-type ESBLs encoding gene of ESBLs-producing Klebsiella pneumoniae and Escherichia coli , and to study the evolution and classification relationships of the ESBLs .

  5. 对肺炎克雷伯氏菌99-799株产生的AmpC型β-内酰胺酶利用分光光度法进行了酶动力学及酶抑制剂抑酶效应的研究。

    The enzyme kinetics of AmpC β - lactamase in Klebsiella pneumoniae 99-799 and the inhibitory activities of β - lactamase inhibitors were studied by spectrophotometry .

  6. 结果2003年有33.3%的肺炎克雷伯氏菌和35.3%大肠埃希氏菌产ESBL,2004年则为29.3%和32.2%;

    Results : Among the strains , 33.3 % of K pneumonia and 35.3 % of E. coli produced ESBL in 2003 , 29.3 % and 32.2 % in 2004 ;

  7. 对环丙沙星耐药的肺炎克雷伯氏菌外膜蛋白图谱分析

    Analysis of outer membrane protein profile of Klebsiella pneumoniae resistant to ciprofloxacin

  8. 中华鳖肺炎克雷伯氏菌病的病原研究

    Studies on the pathogens of the Klebsiella pneumoniae disease of Trionyx sinensis

  9. 肺炎克雷伯氏菌培养工艺的研究

    Study on Culture Technological Conditions of Klebsiella Pneumoniae

  10. 胶囊对肺炎克雷伯氏菌感染小鼠的疗效略强。

    Capsule is slightly stronger to tablet on the curing induced pneumobacillus in mice .

  11. 头孢地秦和阿米卡星治疗肺炎克雷伯氏菌感染对小鼠胸腺细胞凋亡的影响

    Effects of cefodizime and amikacin on thymocyte apoptosis in mice induced by Klebsiella pneumoniae infection

  12. 肺炎克雷伯氏菌荚膜多糖的提取纯化及其对细胞免疫活性的影响

    Extraction and Purification of the Klebsiella pneumoniae Capsular Polysaccharide and the Effection on the Cell Immunoactivity

  13. 对76株肺炎克雷伯氏菌进行13种抗菌药物敏感度及联合药敏试验的研究。

    Antimicrobic susceptibility test of 13 antimicrobic agents in 76 clinical isolates of Klebsiella Pneumoniae was studied .

  14. 肺炎克雷伯氏菌和大肠杆菌是主要病原,分别占47.4%和19.2%;

    Klebsiella pneumoniae and Bacillus coli were major pathogens , respectively occupying 47.4 % and 19.2 % .

  15. 肺炎克雷伯氏菌与大肠埃希氏菌产超广谱β内酰胺酶分别为45%与35%;

    The extended spectrum β lactamase producing strains in E. coli and K. pneumoniae were 35 % and 45 % respectively .

  16. 结论肺炎克雷伯氏菌感染能引起胸腺细胞发生凋亡,应用头孢地秦和阿米卡星能明显抑制胸腺细胞的凋亡。

    Conclusion The apoptosis in thymocyte can be induced by Klebsiella pneumoniae infection and the treatment of cefodizime and amikacin can significantly inhibit the thymocyte apoptosis .

  17. 通过头孢他啶间断腹腔注射及连续腹腔滴注两种给药方式,观察了该药对大鼠肺炎克雷伯氏菌肺炎的疗效。

    By comparing the therapeutic efficacy of continuous intraperitoneal infusion and intermittent intraperitoneal infusion , ceftazidime on the pneumonia infected by Klebsiella pneumoniae in the rats were studied .

  18. 内科、外科、儿科、重症监护病房和门诊患者分离的肺炎克雷伯氏菌耐药性分析

    Study on antimicrobial resistance of Klebsiella pneumoniae isolates collected from the patients of the departments of internal medicine , surgery , paediatric , intensive care unit , and the outpatient

  19. 结果肺癌患者合并院内细菌性肺炎病原细菌主要是革兰氏阴性杆菌,其中肺炎克雷伯氏菌是最常见的条件致病菌。

    Result : G-negative bacilli were the common pathogens in NBP among lung cancer patients , and the Klebsiella pneumoniae was the most common one .